Stability characterizations of feed-based bivalent vaccine containing inactivated Streptococcus agalactiae and Aeromonas hydrophila against streptococcosis and Aeromonas infections in red hybrid tilapia (Oreochromis sp.).

Nur Shidaa Mohd Ali, Mohamad Syazwan Ngalimat, Mohd Zamri Saad, Mohammad Noor Amal Azmai, Annas Salleh, Zarirah Zulperi, Ina Salwany Md Yasin

Abstract read

PubMed Publisher

In one paragraph

Article in Archives of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nur Shidaa Mohd AliLaboratory of Aquatic Animal Health and Therapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Mohamad Syazwan NgalimatDepartment of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Mohd Zamri SaadDepartment of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Mohammad Noor Amal AzmaiLaboratory of Aquatic Animal Health and Therapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Annas SallehDepartment of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Zarirah ZulperiDepartment of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia.

Ina Salwany Md YasinLaboratory of Aquatic Animal Health and Therapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, 43400 UPM, Malaysia. salwany@upm.edu.my.ORCID https://orcid.org/0000-0003-2905-2915

Funding

Geran Putra Berimpak, Universiti Putra Malaysia GPB/2020/9694800HICOE, MoHE 6369100

6 · The paper itself

Abstract

Feed-based bivalent vaccine (FBBV) containing killed whole organism (KWO) of Streptococcus agalactiae and Aeromonas hydrophila with 10% palm oil was previously proved to improve red hybrid tilapia's (Oreochromis sp.) immunity against streptococcosis and Aeromonas infections. This study characterized the FBBV's stability following the preparatory process and storage. The FBBV was prepared, and the KWO's stability was determined microscopically and molecularly. The efficacy of FBBV stored at room temperature (25 ± 2 °C) for 0, 30 and 60 days was investigated in red hybrid tilapia. The results indicated the addition of palm oil was not affecting the KWO's structure and helping in the FBBV's pelletization. In 1 g of FBBV contained 1.5 × 10

Indexed as

Aeromonas hydrophilaBacterial VaccinesFish DiseasesGram-Negative Bacterial InfectionsStreptococcal InfectionsStreptococcus agalactiaeAnimal FeedAnimalsTilapiaVaccines, InactivatedBacterial VaccinesVaccines, InactivatedBacterial diseasesFeed-based vaccine characterizationsStability analysesTilapia

Identifiers

PMID39443367

DOI10.1016/j.dci.2017.07.024

What Socratic holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.